13FGuru
Sign in with Google Sign in with Discord

NYSE · Health Care

JOHNSON & JOHNSON JNJ

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use.

Sources StockAnalysis company profile stockanalysis.com
Pharma / Devices

Company profile

Business mix

  • It operates in two segments, Innovative Medicine and MedTech.
  • The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals.
  • This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures.
  • The company was founded in 1886 and is based in New Brunswick, New Jersey.

Current key questions

  • Can the company's products, services, or pipeline expand adoption within drug manufacturers - general?
  • How do reimbursement, regulation, clinical data, patents, and commercial execution affect growth?
  • Can margins and cash flow improve while funding research, manufacturing, or go-to-market investment?
Holders 9 Current sample portfolio
Public mentions 0 Videos / interviews / letters
Valuation snapshot
PE 26.95 FCF 3.5% Buyback 0.17%
2026-06-07

Current firm holders

Firm Weight Value Filing period
GQG Partners Rajiv Jain 2.8% $1.8B 2026-03-31
Yacktman Asset Management Stephen Yacktman 4.1% $305.4M 2026-03-31
Bridgewater Associates Ray Dalio 0.8% $170.3M 2026-03-31
Markel Group Tom Gayner 1.3% $149.3M 2026-03-31
Gotham Asset Management Joel Greenblatt 0.2% $55.6M 2026-03-31
Tweedy, Browne Company 4.3% $53.7M 2026-03-31
Mar Vista Investment Partners 4.1% $40.6M 2026-03-31
Fairfax Financial Prem Watsa 0.9% $17.9M 2026-03-31
Ariel Investments John Rogers 0.1% $9.9M 2026-03-31

Recent trading changes over the last 2 quarters

Last 1 quarters Last 2 quarters Last 3 quarters Last 4 quarters
Net buyers 2 Last 2 13F filing periods
Net reducers 5 Last 2 13F filing periods
Unchanged holders 2 Share count unchanged
Increase amount $316.3M Estimated from net added shares
Reduction amount $270.0M Estimated from net reduced shares
Net share change / base shares +1.8% +189,419 / 10,411,776
Bridgewater Associates Ray Dalio 2 filing periods
13F 2025-12-31 Filed 2026-02-13
Major reduction Shares -23.4% 13F value change -$46.2M
13F 2026-03-31 Filed 2026-05-15
Major reduction Shares -47.0% 13F value change -$101.6M
Settlement As of 13F 2026-03-31 · Filed 2026-05-15
Base shares 1,715,777 Last 2 periods -1,018,893 (-59.4%) Total shares 696,884 Value $170.3M
Gotham Asset Management Joel Greenblatt 2 filing periods
13F 2025-12-31 Filed 2026-02-17
Minor increase Shares 12.4% 13F value change +$10.0M
13F 2026-03-31 Filed 2026-05-15
Minor reduction Shares -5.0% 13F value change +$6.0M
Settlement As of 13F 2026-03-31 · Filed 2026-05-15
Base shares 213,036 Last 2 periods +14,334 (+6.7%) Total shares 227,370 Value $55.6M
Fairfax Financial Prem Watsa 2 filing periods
13F 2025-12-31 Filed 2026-02-17
Unchanged Shares 0.0% 13F value change $0
13F 2026-03-31 Filed 2026-05-15
Unchanged Shares 0.0% 13F value change $0
Settlement As of 13F 2026-03-31 · Filed 2026-05-15
Base shares 73,400 Last 2 periods +0 (0.0%) Total shares 73,400 Value $17.9M
Ariel Investments John Rogers 2 filing periods
13F 2025-12-31 Filed 2026-02-13
Major reduction Shares -16.6% 13F value change -$662,112
13F 2026-03-31 Filed 2026-05-14
Minor reduction Shares -6.3% 13F value change +$960,118
Settlement As of 13F 2026-03-31 · Filed 2026-05-14
Base shares 51,854 Last 2 periods -11,301 (-21.8%) Total shares 40,553 Value $9.9M
Mar Vista Investment Partners 2 filing periods
13F 2025-12-31 Filed 2026-02-17
Minor reduction Shares -5.8% 13F value change +$1.7M
13F 2026-03-31 Filed 2026-05-13
Minor reduction Shares -2.1% 13F value change +$5.5M
Settlement As of 13F 2026-03-31 · Filed 2026-05-13
Base shares 180,093 Last 2 periods -14,093 (-7.8%) Total shares 166,000 Value $40.6M
GQG Partners Rajiv Jain 2 filing periods
13F 2025-12-31 Filed 2026-02-13
Major increase Shares 28.4% 13F value change +$484.8M
13F 2026-03-31 Filed 2026-05-12
Minor reduction Shares -5.6% 13F value change +$184.3M
Settlement As of 13F 2026-03-31 · Filed 2026-05-12
Base shares 6,037,579 Last 2 periods +1,279,710 (+21.2%) Total shares 7,317,289 Value $1.8B
Tweedy, Browne Company 2 filing periods
13F 2025-12-31 Filed 2026-02-03
Minor reduction Shares -2.4% 13F value change +$4.0M
13F 2026-03-31 Filed 2026-05-06
Minor reduction Shares -7.0% 13F value change +$4.8M
Settlement As of 13F 2026-03-31 · Filed 2026-05-06
Base shares 242,003 Last 2 periods -22,513 (-9.3%) Total shares 219,490 Value $53.7M
Markel Group Tom Gayner 2 filing periods
13F 2025-12-31 Filed 2026-02-06
Unchanged Shares 0.0% 13F value change $0
13F 2026-03-31 Filed 2026-05-01
Unchanged Shares 0.0% 13F value change $0
Settlement As of 13F 2026-03-31 · Filed 2026-05-01
Base shares 610,800 Last 2 periods +0 (0.0%) Total shares 610,800 Value $149.3M
Yacktman Asset Management Stephen Yacktman 2 filing periods
13F 2025-12-31 Filed 2026-02-03
Minor reduction Shares -2.7% 13F value change +$20.6M
13F 2026-03-31 Filed 2026-05-01
Minor reduction Shares -0.3% 13F value change +$46.2M
Settlement As of 13F 2026-03-31 · Filed 2026-05-01
Base shares 1,287,234 Last 2 periods -37,825 (-2.9%) Total shares 1,249,409 Value $305.4M

Recent mentions

No public mentions.